Logo image of 1SHL.MI

SIEMENS HEALTHINEERS AG (1SHL.MI) Stock Fundamental Analysis

BIT:1SHL - Euronext Milan - DE000SHL1006 - Common Stock - Currency: EUR

47.06  -0.63 (-1.32%)

Fundamental Rating

5

Taking everything into account, 1SHL scores 5 out of 10 in our fundamental rating. 1SHL was compared to 58 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of 1SHL while its profitability can be described as average. 1SHL is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year 1SHL was profitable.
1SHL had a positive operating cash flow in the past year.
Each year in the past 5 years 1SHL has been profitable.
Each year in the past 5 years 1SHL had a positive operating cash flow.
1SHL.MI Yearly Net Income VS EBIT VS OCF VS FCF1SHL.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

1.2 Ratios

1SHL has a better Return On Assets (4.45%) than 61.54% of its industry peers.
The Return On Equity of 1SHL (11.19%) is better than 72.31% of its industry peers.
1SHL has a Return On Invested Capital of 7.37%. This is in the better half of the industry: 1SHL outperforms 64.62% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1SHL is below the industry average of 8.02%.
The 3 year average ROIC (5.87%) for 1SHL is below the current ROIC(7.37%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.45%
ROE 11.19%
ROIC 7.37%
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
1SHL.MI Yearly ROA, ROE, ROIC1SHL.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

1SHL's Profit Margin of 9.03% is fine compared to the rest of the industry. 1SHL outperforms 63.08% of its industry peers.
In the last couple of years the Profit Margin of 1SHL has declined.
Looking at the Operating Margin, with a value of 13.67%, 1SHL is in the better half of the industry, outperforming 63.08% of the companies in the same industry.
In the last couple of years the Operating Margin of 1SHL has declined.
The Gross Margin of 1SHL (38.77%) is worse than 78.46% of its industry peers.
In the last couple of years the Gross Margin of 1SHL has remained more or less at the same level.
Industry RankSector Rank
OM 13.67%
PM (TTM) 9.03%
GM 38.77%
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
1SHL.MI Yearly Profit, Operating, Gross Margins1SHL.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

3

2. Health

2.1 Basic Checks

1SHL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
1SHL has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, 1SHL has more shares outstanding
1SHL has a better debt/assets ratio than last year.
1SHL.MI Yearly Shares Outstanding1SHL.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
1SHL.MI Yearly Total Debt VS Total Assets1SHL.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

An Altman-Z score of 1.94 indicates that 1SHL is not a great score, but indicates only limited risk for bankruptcy at the moment.
1SHL has a Altman-Z score (1.94) which is in line with its industry peers.
The Debt to FCF ratio of 1SHL is 6.06, which is on the high side as it means it would take 1SHL, 6.06 years of fcf income to pay off all of its debts.
1SHL has a Debt to FCF ratio (6.06) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.65 indicates that 1SHL is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.65, 1SHL is not doing good in the industry: 70.77% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 6.06
Altman-Z 1.94
ROIC/WACC1.23
WACC5.97%
1SHL.MI Yearly LT Debt VS Equity VS FCF1SHL.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

1SHL has a Current Ratio of 1.10. This is a normal value and indicates that 1SHL is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.10, 1SHL is not doing good in the industry: 75.38% of the companies in the same industry are doing better.
A Quick Ratio of 0.76 indicates that 1SHL may have some problems paying its short term obligations.
With a Quick ratio value of 0.76, 1SHL is not doing good in the industry: 72.31% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 0.76
1SHL.MI Yearly Current Assets VS Current Liabilites1SHL.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

5

3. Growth

3.1 Past

1SHL shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.12%.
1SHL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.27% yearly.
Looking at the last year, 1SHL shows a small growth in Revenue. The Revenue has grown by 5.83% in the last year.
The Revenue has been growing by 9.02% on average over the past years. This is quite good.
EPS 1Y (TTM)5.12%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%1.82%
Revenue 1Y (TTM)5.83%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%8.72%

3.2 Future

Based on estimates for the next years, 1SHL will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.52% on average per year.
Based on estimates for the next years, 1SHL will show a small growth in Revenue. The Revenue will grow by 5.02% on average per year.
EPS Next Y12.21%
EPS Next 2Y13.11%
EPS Next 3Y12.78%
EPS Next 5Y9.52%
Revenue Next Year5.7%
Revenue Next 2Y5.9%
Revenue Next 3Y6.04%
Revenue Next 5Y5.02%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1SHL.MI Yearly Revenue VS Estimates1SHL.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B
1SHL.MI Yearly EPS VS Estimates1SHL.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 20.82, 1SHL is valued on the expensive side.
Based on the Price/Earnings ratio, 1SHL is valued a bit cheaper than 75.38% of the companies in the same industry.
1SHL is valuated rather cheaply when we compare the Price/Earnings ratio to 27.45, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 16.49, 1SHL is valued correctly.
1SHL's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. 1SHL is cheaper than 70.77% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.90. 1SHL is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 20.82
Fwd PE 16.49
1SHL.MI Price Earnings VS Forward Price Earnings1SHL.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, 1SHL is valued a bit cheaper than the industry average as 72.31% of the companies are valued more expensively.
1SHL's Price/Free Cash Flow ratio is rather cheap when compared to the industry. 1SHL is cheaper than 84.62% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.09
EV/EBITDA 15.2
1SHL.MI Per share data1SHL.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

1SHL's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of 1SHL may justify a higher PE ratio.
A more expensive valuation may be justified as 1SHL's earnings are expected to grow with 12.78% in the coming years.
PEG (NY)1.71
PEG (5Y)2.86
EPS Next 2Y13.11%
EPS Next 3Y12.78%

5

5. Dividend

5.1 Amount

1SHL has a Yearly Dividend Yield of 2.05%.
Compared to an average industry Dividend Yield of 2.07, 1SHL pays a better dividend. On top of this 1SHL pays more dividend than 83.08% of the companies listed in the same industry.
1SHL's Dividend Yield is comparable with the S&P500 average which is at 2.42.
Industry RankSector Rank
Dividend Yield 2.05%

5.2 History

The dividend of 1SHL is nicely growing with an annual growth rate of 6.35%!
Dividend Growth(5Y)6.35%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

101.91% of the earnings are spent on dividend by 1SHL. This is not a sustainable payout ratio.
The dividend of 1SHL is growing, but earnings are growing more, so the dividend growth is sustainable.
DP101.91%
EPS Next 2Y13.11%
EPS Next 3Y12.78%
1SHL.MI Yearly Income VS Free CF VS Dividend1SHL.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
1SHL.MI Dividend Payout.1SHL.MI Dividend Payout, showing the Payout Ratio.1SHL.MI Dividend Payout.PayoutRetained Earnings

SIEMENS HEALTHINEERS AG

BIT:1SHL (5/29/2025, 7:00:00 PM)

47.06

-0.63 (-1.32%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)07-30 2025-07-30
Inst Owners10.84%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap53.08B
Analysts83.7
Price Target62.27 (32.32%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.05%
Yearly Dividend0.95
Dividend Growth(5Y)6.35%
DP101.91%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.12%
Min EPS beat(2)-2.04%
Max EPS beat(2)8.28%
EPS beat(4)2
Avg EPS beat(4)2.45%
Min EPS beat(4)-2.04%
Max EPS beat(4)8.28%
EPS beat(8)5
Avg EPS beat(8)1.99%
EPS beat(12)7
Avg EPS beat(12)1.43%
EPS beat(16)10
Avg EPS beat(16)3.47%
Revenue beat(2)2
Avg Revenue beat(2)0.78%
Min Revenue beat(2)0.27%
Max Revenue beat(2)1.29%
Revenue beat(4)2
Avg Revenue beat(4)-0.57%
Min Revenue beat(4)-3.02%
Max Revenue beat(4)1.29%
Revenue beat(8)3
Avg Revenue beat(8)-0.42%
Revenue beat(12)5
Avg Revenue beat(12)-0.35%
Revenue beat(16)9
Avg Revenue beat(16)0.75%
PT rev (1m)-3.32%
PT rev (3m)-2.71%
EPS NQ rev (1m)-5.19%
EPS NQ rev (3m)-5.75%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.33%
Revenue NQ rev (1m)-1.91%
Revenue NQ rev (3m)-2.14%
Revenue NY rev (1m)-0.23%
Revenue NY rev (3m)-0.23%
Valuation
Industry RankSector Rank
PE 20.82
Fwd PE 16.49
P/S 2.29
P/FCF 19.09
P/OCF 14.98
P/B 2.84
P/tB N/A
EV/EBITDA 15.2
EPS(TTM)2.26
EY4.8%
EPS(NY)2.85
Fwd EY6.06%
FCF(TTM)2.46
FCFY5.24%
OCF(TTM)3.14
OCFY6.67%
SpS20.52
BVpS16.55
TBVpS-5.76
PEG (NY)1.71
PEG (5Y)2.86
Profitability
Industry RankSector Rank
ROA 4.45%
ROE 11.19%
ROCE 9.41%
ROIC 7.37%
ROICexc 8.05%
ROICexgc 44.05%
OM 13.67%
PM (TTM) 9.03%
GM 38.77%
FCFM 12.01%
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
ROICexc(3y)6.25%
ROICexc(5y)6.86%
ROICexgc(3y)30.57%
ROICexgc(5y)31.67%
ROCE(3y)7.49%
ROCE(5y)8.29%
ROICexcg growth 3Y-8.79%
ROICexcg growth 5Y-3.88%
ROICexc growth 3Y1.69%
ROICexc growth 5Y-10.54%
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
F-Score8
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 6.06
Debt/EBITDA 2.78
Cap/Depr 62.49%
Cap/Sales 3.3%
Interest Coverage 7.53
Cash Conversion 80.8%
Profit Quality 133.08%
Current Ratio 1.1
Quick Ratio 0.76
Altman-Z 1.94
F-Score8
WACC5.97%
ROIC/WACC1.23
Cap/Depr(3y)58.06%
Cap/Depr(5y)61.48%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3.7%
Profit Quality(3y)91.88%
Profit Quality(5y)100.74%
High Growth Momentum
Growth
EPS 1Y (TTM)5.12%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%1.82%
EPS Next Y12.21%
EPS Next 2Y13.11%
EPS Next 3Y12.78%
EPS Next 5Y9.52%
Revenue 1Y (TTM)5.83%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%8.72%
Revenue Next Year5.7%
Revenue Next 2Y5.9%
Revenue Next 3Y6.04%
Revenue Next 5Y5.02%
EBIT growth 1Y21.23%
EBIT growth 3Y3.18%
EBIT growth 5Y4.12%
EBIT Next Year49.6%
EBIT Next 3Y21.79%
EBIT Next 5Y15.66%
FCF growth 1Y102.62%
FCF growth 3Y-1.94%
FCF growth 5Y15.48%
OCF growth 1Y57.68%
OCF growth 3Y-1.23%
OCF growth 5Y11.83%